<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2658-6533-2020-7-1-0-3</article-id><article-id pub-id-type="publisher-id">2280</article-id><article-categories><subj-group subj-group-type="heading"><subject>Genetics</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;Associations of rs2305948 and rs1870377 polymorphic variants of the vascular endothelial growth factor receptor type 2 (KDR) gene with the risk of coronary heart disease&lt;/strong&gt;&lt;br /&gt;
&amp;nbsp;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;Associations of rs2305948 and rs1870377 polymorphic variants of the vascular endothelial growth factor receptor type 2 (KDR) gene with the risk of coronary heart disease&lt;/strong&gt;&lt;br /&gt;
&amp;nbsp;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Medvedeva</surname><given-names>Maria V.</given-names></name><name xml:lang="en"><surname>Medvedeva</surname><given-names>Maria V.</given-names></name></name-alternatives><email>medvedevamariakgavm@yandex.ru</email></contrib></contrib-group><pub-date pub-type="epub"><year>2021</year></pub-date><volume>7</volume><issue>1</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2021/1/document-34-45.pdf" /><abstract xml:lang="ru"><p>Background: According to statistics, the first place among the causes of death worldwide is occupied by cardiovascular diseases (CVD), of which a large proportion are cases of coronary heart disease (CHD). In this regard, to date, research is actively being conducted to study its previously unknown etiological aspects. Especially relevant in modern conditions is the search for genetic markers of the disease, potentially applicable in the future for the early diagnosis of CHD, as well as the establishment of a hereditary predisposition to it. The aim of the study: To study the association of polymorphic variants of rs2305948 and rs1870377 of the KDR gene with the risk of CHD in Central Russia. Materials and methods: The study included 1390 DNA samples: 635 CHD patients and 755 healthy people. DNA was isolated by phenol-chloroform extraction. Genotyping of DNA polymorphisms was performed using real-time PCR with allele discrimination using TaqMan probes. We used the CFX96 amplifier and Applied Biosystems kits. Statistical processing of results was carried out using the resources of the SNPstats program. We performed functional annotation of SNPs on the basis of available bioinformatic resources. Results: We found that there is sexual dimorphism in relation to KDR with the development of CHD. We found a statistically significant Association of the a/T rs1870377 genotype of the VDR gene with the risk of CHD in men. Bioinformatic analysis revealed the relationship of rs1870377 polymorphism with increased expression of the SRD5A gene (an enzyme that converts testosterone to dihydrotestosterone), which may be one of the reasons for gender differences in studying the risk of CHD in this particular case. Conclusion: For the first time in the Russian population, the study examined the relationship of polymorphic variants of the KDR gene with the risk of CHD. It was found that the rs1870377 polymorphism of the KDR gene is statistically significantly associated with risk of CHD in males.</p></abstract><trans-abstract xml:lang="en"><p>Background: According to statistics, the first place among the causes of death worldwide is occupied by cardiovascular diseases (CVD), of which a large proportion are cases of coronary heart disease (CHD). In this regard, to date, research is actively being conducted to study its previously unknown etiological aspects. Especially relevant in modern conditions is the search for genetic markers of the disease, potentially applicable in the future for the early diagnosis of CHD, as well as the establishment of a hereditary predisposition to it. The aim of the study: To study the association of polymorphic variants of rs2305948 and rs1870377 of the KDR gene with the risk of CHD in Central Russia. Materials and methods: The study included 1390 DNA samples: 635 CHD patients and 755 healthy people. DNA was isolated by phenol-chloroform extraction. Genotyping of DNA polymorphisms was performed using real-time PCR with allele discrimination using TaqMan probes. We used the CFX96 amplifier and Applied Biosystems kits. Statistical processing of results was carried out using the resources of the SNPstats program. We performed functional annotation of SNPs on the basis of available bioinformatic resources. Results: We found that there is sexual dimorphism in relation to KDR with the development of CHD. We found a statistically significant Association of the a/T rs1870377 genotype of the VDR gene with the risk of CHD in men. Bioinformatic analysis revealed the relationship of rs1870377 polymorphism with increased expression of the SRD5A gene (an enzyme that converts testosterone to dihydrotestosterone), which may be one of the reasons for gender differences in studying the risk of CHD in this particular case. Conclusion: For the first time in the Russian population, the study examined the relationship of polymorphic variants of the KDR gene with the risk of CHD. It was found that the rs1870377 polymorphism of the KDR gene is statistically significantly associated with risk of CHD in males.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ischemic heart disease</kwd><kwd>vascular endothelial growth factor type 2 gene (KDR)</kwd><kwd>single nucleotide polymorphism (SNP)</kwd><kwd>association analysis</kwd><kwd>sex dimorphism</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ischemic heart disease</kwd><kwd>vascular endothelial growth factor type 2 gene (KDR)</kwd><kwd>single nucleotide polymorphism (SNP)</kwd><kwd>association analysis</kwd><kwd>sex dimorphism</kwd></kwd-group></article-meta></front><back><ack><p>We would like to thank the research Institute of genetic and molecular epidemiology of the KSMU for their assistance in the implementation of this study. The author expresses his gratitude to Solodilova Maria Andreevna, professor of the Department of Biology, Medical Genetics and Ecology of Kursk State Medical University, Doctor of Biological Sciences, for scientific guidance and support in this research.</p></ack><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Latfullin IL. Ischaemic heart disease: the main risk factors, treatment. Kazan: Kazan Publishing house; 2017. Russian.</mixed-citation></ref><ref id="B2"><mixed-citation>Abrosimov VN, Zhukova LA, Glotov SI, et al. Ischemic heart disease: a tutorial. Ryazan: Izd-vo Ryazanskogo gos. med. un-ta; 2015. Russian.</mixed-citation></ref><ref id="B3"><mixed-citation>Moskalenko MI, Ponоmarenko IV, Polоnikov AV, et al. Polymоrphic lоcus rs17577 оf MMP9 gеne is assоciated with еssential hypеrtension in mеn. Medical News of the Nоrth Cauсasus. 2020;15(1):39-43. DOI: https://doi.org/10.14300/mnnc.2020.15008</mixed-citation></ref><ref id="B4"><mixed-citation>Moskalenko MI, Ponomarenko IV, Polonikov AV, et al. Polymorphic locus rs652438 of the MMP12 gene is associated with the development of hypertension in women. &amp;quot;Arterial&amp;rsquo;naya Gipertenziya&amp;quot; (&amp;quot;Arterial Hypertension&amp;quot;). 2019;25(1):60-65. Russian. DOI: https://doi.org/10.18705/1607-419X-2019-25-1-60-65</mixed-citation></ref><ref id="B5"><mixed-citation>Khokhlov AL, Pozdnyakov NO, Miroshnikov AE, et al. Polymorphism of the eNOS and AGTR2 genes as a risk factor for coronary heart disease. Problems of standardization in healthcare. 2015;9-10:46-50. Russian.</mixed-citation></ref><ref id="B6"><mixed-citation>Boytsov SA, Zayratiants OV, Andreev EM, et al. Comparison of coronary heart disease mortality in 50-years-old and older men and women age in Russia and USA. Russian Journal of Cardiology. 2017;(6):100-107. Russian. DOI: https://doi.org/10.15829/1560-4071-2017-6-100-107</mixed-citation></ref><ref id="B7"><mixed-citation>WHO Mortality Database [Internet] [cited 2020 July 27]. Available from: http://www.who.int/healthinfo/statistics/ mortalityrawdata/en/</mixed-citation></ref><ref id="B8"><mixed-citation>Skvortsov VV, Tumarenko AV, Skvortsova EM, et al. Coronary heart disease and angina. Nurse. 2015;7:3-9.</mixed-citation></ref><ref id="B9"><mixed-citation>Bochkov NP, Puzyrev VP, Smirnova SA. Clinical genetics. Moscow: GEOTAR-Media; 2015. Russian.</mixed-citation></ref><ref id="B10"><mixed-citation>Brown BD, Nsengimana J, Barrett JH, et al. An evaluation of inflammatory gene polymorphisms in sibships discordant for premature coronary artery disease: the GRACE-IMMUNE study. BMC Medicine. 2010;8:5. DOI: https://doi.org/10.1186/1741-7015-8-5</mixed-citation></ref><ref id="B11"><mixed-citation>Khokhlov AL, Pozdnyakov NO, Miroshnikov AE, et al. Features of the clinical significance of polymorphic variants of the ENOS and AGTR2 genes in patients with CHD. The Russian Archives of Internal Medicine. 2016;29(3):53-58. Russian. DOI: https://doi.org/10.20514/2226-6704-2016-6-3-53-58</mixed-citation></ref><ref id="B12"><mixed-citation>Khera AV, Kathiresan S. Genetics of coronary artery disease: discovery, biology and clinical translation. Nature Reviews Genetics. 2017;18(6):331-344. DOI: https://doi.org/10.1038/nrg.2016.160</mixed-citation></ref><ref id="B13"><mixed-citation>Wang Y, Huang Q, Liu J, et al. Vascular endothelial growth factor A polymorphisms are associated with increased risk of coronary heart disease: a meta-analysis. Oncotarget. 2017;8(18):30539-30551. DOI: https://doi.org/10.18632/oncotarget.15546</mixed-citation></ref><ref id="B14"><mixed-citation>Ma WQ, Wang Y, Han XQ, et al. Association of genetic polymorphisms in vascular endothelial growth factor with susceptibility to coronary artery disease: a meta-analysis. BMC Medical Genetics. 2018;19(1):108. DOI: https://doi.org/10.1186/s12881-018-0628-3</mixed-citation></ref><ref id="B15"><mixed-citation>Zhao X, Meng L, Jiang J, et al. Vascular endothelial growth factor gene polymorphisms and coronary heart disease: a systematic review and meta-analysis. Growth Factors. 2018;36(3-4):153-163. DOI: https://doi.org/10.1080/08977194.2018.1477141</mixed-citation></ref><ref id="B16"><mixed-citation>Zhang W, Sun K, Zhen Y, et al. VEGF receptor-2 variants are associated with susceptibility to stroke and recurrence. Stroke. 2009;40(8):2720-2726. DOI: https://doi.org/10.1161/STROKEAHA.109.554394</mixed-citation></ref><ref id="B17"><mixed-citation>Wang Y, Zheng Y, Zhang W, et al. Polymorphisms of KDR gene are associated with coronary heart disease. Journal of the American College of Cardiology. 2007;50(8):760-767. DOI: https://doi.org/10.1016/j.jacc.2007.04.074</mixed-citation></ref><ref id="B18"><mixed-citation>Kariyazono H, Ohno T, Khajoee V, et al. Association of vascularendothelial growth factor (VEGF) and VEGF receptor gene polymor-phisms with coronary artery lesions of Kawasaki disease. Pediatric Research. 2004;56:953-959. DOI: https://doi.org/10.1203/01.PDR.0000145280.26284.B9</mixed-citation></ref><ref id="B19"><mixed-citation>Liu D, Song J, Ji X, et al. Association of Genetic Polymorphisms on VEGFA and VEGFR2 With Risk of Coronary Heart Disease. Medicine. 2016;95(19):e3413. DOI: https://doi.org/10.1097/md.0000000000003413</mixed-citation></ref><ref id="B20"><mixed-citation>Li L, Pan Y, Dai L, et al. Association of Genetic Polymorphisms on Vascular Endothelial Growth Factor and its Receptor Genes with Susceptibility to Coronary Heart Disease. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2016;22:31-40. DOI: https://doi.org/10.12659/MSM.895163</mixed-citation></ref><ref id="B21"><mixed-citation>Polonikov AV, Ushachev DV, Shestakov AM, et al. Polymorphism Gly460Trp of alpha-adducin gene and predisposition to essential hypertension. The role of gene-environment interactions in the development of the disease in Russian population. Cardiology. 2011;11(10):33. Russian.</mixed-citation></ref><ref id="B22"><mixed-citation>Polonikov AV, Solodilova MA, Ivanov VP, et al. Protective effect of GLY272SER polymorphism of the GNB3 gene in the development of hypertension and its relationship with environmental risk factors for the development of the disease. Terapevticheskiy arkhiv. 2011;83(4):55. Russian.</mixed-citation></ref><ref id="B23"><mixed-citation>Polonikov AV, Ivanov VP, Solodilova MA. Promoter polymorphism-1293G&amp;gt;C of the CYP2E1 gene increases the risk of developing hypertension in men who abuse alcohol. Bulletin of Experimental Biology and Medicine. 2013;155(6):695-698. Russian. DOI: https://doi.org/10.1007/s10517-013-2239-5</mixed-citation></ref><ref id="B24"><mixed-citation>Bushueva OY, Bulgakova IV, Ivanov VP, et al. Association of e158k polymorphism of the flavin monooxygenase 3 gene with the risk of ischemic heart disease. Bulletin of Experimental Biology and Medicine. 2015;159(6):754. Russian. DOI: https://doi.org/10.1007/s10517-015-3073-8</mixed-citation></ref><ref id="B25"><mixed-citation>Churilin MI, Kononov SI, Luneva YV, et al. Polymorphic variants of genes of intracellular cholesterol transporters: connection with blood lipids level, intima-media thickness and development of ischemic heart disease. Genetics. 2020;56(2):225-233. Russian.</mixed-citation></ref><ref id="B26"><mixed-citation>Sol&amp;eacute; X, Guin&amp;oacute; E, Valls J, et al. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006;22(15):1928-1929. DOI: https://doi.org/10.1093/bioinformatics/btl268</mixed-citation></ref><ref id="B27"><mixed-citation>Simons M, Gordon E, Claesson-Welsh L. Mechanisms and regulation of endothelial VEGF receptor signalling. Nature Reviews Molecular Cell Biology. 2016;17(10):611-625. DOI: https://doi.org/10.1038/nrm.2016.87</mixed-citation></ref><ref id="B28"><mixed-citation>Zafar MI, Zheng J, Kong W, et al. The role of vascular endothelial growth factor-B in metabolic homoeostasis: current evidence. Bioscience Reports. 2017;37(4):BSR20171089. DOI: https://doi.org/10.1042/BSR20171089</mixed-citation></ref><ref id="B29"><mixed-citation>Yamaoka-Tojo M. Endothelial Function for Cardiovascular Disease Prevention and Management. International Journal of Clinical Cardiology. 2017;4:103. DOI: https://doi.org/10.23937/2378-2951/1410103</mixed-citation></ref><ref id="B30"><mixed-citation>Tsygankova O.V. Etiopathogenetic features of ischemic heart disease depending on the level of sex hormones, gender and age [dissertation]. Novosibirsk: Pirogov Russian National Research Medical University; 2016. Russian.</mixed-citation></ref><ref id="B31"><mixed-citation>Azzouni F, Mohler J. Role of 5&amp;alpha;-reductase inhibitors in prostate cancer prevention and treatment.&amp;nbsp;Urology. 2012;79(6):1197-1205. DOI: https://doi.org/10.1016/j.urology.2012.01.024</mixed-citation></ref></ref-list></back></article>